Concepedia

Maicol Mancini

MM

Statistics

Publications

14

Citations

811

H-Index

13

Active since

2013

Affiliations

Weizmann Institute of Science(Current)

Institut de Recherche en Cancérologie de Montpellier

Inserm

Université de Montpellier

Kaplan Medical Center

Maicol Mancini is an author at Weizmann Institute of Science specializing in tumor biology, tumor microenvironment, and medicine.

ORCID

Top concepts

Publications per year

2013–2021

14

Publications

14

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth

Georg Mahlknecht, Ruth Maron, Maicol Mancini et al. · Proceedings of the National Academy of Sciences · 2013 · 158 citations · Full text

A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

Donatella Romaniello, Luigi Mazzeo, Maicol Mancini et al. · Clinical Cancer Research · 2018 · 83 citations · Full text

EGF induces microRNAs that target suppressors of cell migration: miR-15b targets <i>MTSS1</i> in breast cancer

Merav Kedmi, Nir Ben‐Chetrit, Cindy Körner et al. · Science Signaling · 2015 · 81 citations · Full text

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer

Nir Ben‐Chetrit, David Chetrit, Roslin Russell et al. · Science Signaling · 2015 · 77 citations · Full text

, , +15

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2

Ruth Maron, Bilha Schechter, Maicol Mancini et al. · Proceedings of the National Academy of Sciences · 2013 · 57 citations · Full text

, , +13

1–5 of 14